US 6312718
Vaccine for B-cell malignancies
expired A61KA61K2039/55511A61K39/395
Quick answer
US patent 6312718 (Vaccine for B-cell malignancies) held by Biomira USA Inc. expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Biomira USA Inc.
- Grant date
- Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/55511, A61K39/395, A61K9/127, A61P